Advisor Group Holdings, Inc. Alkermes Plc. Call Options Transaction History
Advisor Group Holdings, Inc.
- $39.8 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ALKS
# of Institutions
365Shares Held
176MCall Options Held
166KPut Options Held
118K-
Black Rock Inc. New York, NY29.1MShares$975 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$620 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$435 Million0.04% of portfolio
-
State Street Corp Boston, MA9.19MShares$308 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.01MShares$235 Million0.04% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.5B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...